|Bid||1.1350 x 2041500|
|Ask||1.1600 x 261700|
|Day's range||1.1300 - 1.1800|
|52-week range||0.9700 - 1.7450|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||26 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
How far off is Aroa Biosurgery Limited ( ASX:ARX ) from its intrinsic value? Using the most recent financial data...
New U.S. Clinical studies provide further validation for Aroa Biosurgery's Myriad™ as products also approved for use in India.
Every investor in Aroa Biosurgery Limited (ASX:ARX) should be aware of the most powerful shareholder groups. Insiders...